← Back
$CPRX All transactions

CATALYST PHARMACEUTICALS, INC.

F

$ Value

Shares

2,492

Price

Filed

Dec 10

Insider

Name

Del Carmen Jeffrey

Title

Chief Commercial Officer

CIK

0001816477

Roles

Officer

Transaction Details

Transaction Date

2025-12-08

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

9,509

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. | Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock. | Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025, and 1/3rd on December 8, 2026. | Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 8, 2025.

Filing Info

Accession No.

0001161697-25-000443

Form Type

4

Issuer CIK

0001369568

Del Carmen Jeffrey's History

Date Ticker Type Value
2025-12-29 CPRX M
2025-12-29 CPRX F
2025-12-29 CPRX M $0
2025-12-08 CPRX M
2025-12-08 CPRX F
2025-12-08 CPRX M $0
2025-11-26 CPRX M $46K
2025-11-26 CPRX $256K
2025-11-26 CPRX M $0
2025-11-21 CPRX M

Other Insiders at CPRX (90d)

Insider Bought Sold Last
Russo Gregg
Chief HR Officer
2026-02-17